Mucin-Type O-Glycans: Barrier, Microbiota, and Immune Anchors in Inflammatory Bowel Disease

References

• Francescone R, Hou V, Grivennikov SI. Cytokines, IBD, and colitis-associated cancer. Inflamm Bowel Dis. 2015;21(2):409–418. doi:10.1097/MIB.0000000000000236
   PubMed Web of Science ®Google Scholar
• Wlodarska M, Kostic AD, Xavier RJ. An integrative view of microbiome-host interactions in inflammatory bowel diseases. Cell Host Microbe. 2015;17(5):577–591. doi:10.1016/j.chom.2015.04.008
   PubMed Web of Science ®Google Scholar
• Imhann F, Vich Vila A, Bonder MJ, et al. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut. 2018;67(1):108–119. doi:10.1136/gutjnl-2016-312135
   PubMed Web of Science ®Google Scholar
• Paone P, Cani PD. Mucus barrier, mucins and gut microbiota: the expected slimy partners? Gut. 2020;69(12):2232–2243. doi:10.1136/gutjnl-2020-322260
   PubMed Web of Science ®Google Scholar
• Lamont JT. Mucus: the front line of intestinal mucosal defense. Ann N Y Acad Sci. 1992;664:190–201. doi:10.1111/j.1749-6632.1992.tb39760.x
   PubMed Web of Science ®Google Scholar
• Kim JJ, Khan WI. Goblet cells and mucins: role in innate defense in enteric infections. Pathogens. 2013;2(1):55–70. doi:10.3390/pathogens2010055
   PubMedGoogle Scholar
• Sun J, Shen X, Li Y, et al. Therapeutic potential to modify the mucus barrier in inflammatory bowel disease. Nutrients. 2016;8(1):44. doi:10.3390/nu8010044
   PubMed Web of Science ®Google Scholar
• Bergstrom K, Shan X, Casero D, et al. Proximal colon–derived O-glycosylated mucus encapsulates and modulates the microbiota. Science. 2020;370(6515):467–472. doi:10.1126/science.aay7367
   PubMed Web of Science ®Google Scholar
• Johansson MEV, Gustafsson JK, Sjöberg KE, et al. Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS One. 2010;5(8):e12238. doi:10.1371/journal.pone.0012238
   PubMed Web of Science ®Google Scholar
• Johansson MEV, Gustafsson JK, Holmén-Larsson J, et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut. 2014;63(2):281–291. doi:10.1136/gutjnl-2012-303207
   PubMed Web of Science ®Google Scholar
• Gum JR, Hicks JW, Gillespie AM, et al. Goblet cell-specific expression mediated by the MUC2 mucin gene promoter in the intestine of transgenic mice. Am J Physiol. 1999;276(3):G666–G676.
   PubMedGoogle Scholar
• Johansson MEV, Sjövall H, Hansson GC. The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol. 2013;10(6):352–361. doi:10.1038/nrgastro.2013.35
   PubMed Web of Science ®Google Scholar
• Pelaseyed T, Bergström JH, Gustafsson JK, et al. The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system. Immunol Rev. 2014;260(1):8–20. doi:10.1111/imr.12182
   PubMed Web of Science ®Google Scholar
• De Weirdt R, Van de Wiele T. Micromanagement in the gut: microenvironmental factors govern colon mucosal biofilm structure and functionality. NPJ Biofilms Microbiomes. 2015;1:15026. doi:10.1038/npjbiofilms.2015.26
   PubMed Web of Science ®Google Scholar
• Li H, Limenitakis JP, Ganal SC, Macpherson AJ. Penetrability of the inner mucus layer: who is out there? EMBO Rep. 2015;16(2):127–129. doi:10.15252/embr.201439943
   PubMed Web of Science ®Google Scholar
• Sicard J-F, Le Bihan G, Vogeleer P, Jacques M, Harel J. Interactions of intestinal bacteria with components of the intestinal mucus. Front Cell Infect Microbiol. 2017;1:7.
   Google Scholar
• Johansson MEV, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc National Acad Sci. 2008;105(39):15064–15069. doi:10.1073/pnas.0803124105
   PubMed Web of Science ®Google Scholar
• van der Post S, Jabbar KS, Birchenough G, et al. Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis. Gut. 2019;68(12):2142–2151. doi:10.1136/gutjnl-2018-317571
   PubMed Web of Science ®Google Scholar
• Da Silva S, Robbe-Masselot C, Ait-Belgnaoui A, et al. Stress disrupts intestinal mucus barrier in rats via mucin O-glycosylation shift: prevention by a probiotic treatment. Am J Physiol Gastrointest Liver Physiol. 2014;307(4):G420–G429. doi:10.1152/ajpgi.00290.2013
   PubMed Web of Science ®Google Scholar
• Bergstrom K, Liu X, Zhao Y, et al. Defective intestinal mucin-type O-glycosylation causes spontaneous colitis-associated cancer in mice. Gastroenterology. 2016;151(1):152–164.e11. doi:10.1053/j.gastro.2016.03.039
   PubMed Web of Science ®Google Scholar
• Larsson JMH, Karlsson H, Crespo JG, et al. Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation. Inflamm Bowel Dis. 2011;17(11):2299–2307. doi:10.1002/ibd.21625
   PubMed Web of Science ®Google Scholar
• Timpte CS, Eckhardt AE, Abernethy JL, Hill RL. Porcine submaxillary gland apomucin contains tandemly repeated, identical sequences of 81 residues. J Biol Chem. 1988;263(2):1081–1088. doi:10.1016/S0021-9258(19)35463-8
   PubMed Web of Science ®Google Scholar
• Gupta R, Jentoft N. Subunit structure of porcine submaxillary mucin. Biochemistry. 1989;28(14):6114–6121. doi:10.1021/bi00440a058
   PubMed Web of Science ®Google Scholar
• Corfield AP, Berry M. Glycan variation and evolution in the eukaryotes. Trends Biochem Sci. 2015;40(7):351–359. doi:10.1016/j.tibs.2015.04.004
   PubMed Web of Science ®Google Scholar
• Martens EC, Neumann M, Desai MS. Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier. Nat Rev Microbiol. 2018;16(8):457–470. doi:10.1038/s41579-018-0036-x
   PubMed Web of Science ®Google Scholar
• Bennett EP, Mandel U, Clausen H, Gerken TA, Fritz TA, Tabak LA. Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. Glycobiology. 2012;22(6):736–756. doi:10.1093/glycob/cwr182
   PubMed Web of Science ®Google Scholar
• Schnaar RL. Glycobiology simplified: diverse roles of glycan recognition in inflammation. J Leukoc Biol. 2016;99(6):825–838. doi:10.1189/jlb.3RI0116-021R
   PubMed Web of Science ®Google Scholar
• Fu J, Wei B, Wen T, et al. Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. J Clin Invest. 2011;121(4):1657–1666. doi:10.1172/JCI45538
   PubMed Web of Science ®Google Scholar
• Moran AP, Gupta A, Joshi L. Sweet-talk: role of host glycosylation in bacterial pathogenesis of the gastrointestinal tract. Gut. 2011;60(10):1412–1425. doi:10.1136/gut.2010.212704
   PubMed Web of Science ®Google Scholar
• Johansson MEV, Thomsson KA, Hansson GC. Proteomic analyses of the two mucus layers of the colon barrier reveal that their main component, the Muc2 mucin, is strongly bound to the fcgbp protein. J Proteome Res. 2009;8(7):3549–3557. doi:10.1021/pr9002504
   PubMed Web of Science ®Google Scholar
• Jensen PH, Kolarich D, Packer NH. Mucin-type O-glycosylation–putting the pieces together. FEBS J. 2010;277(1):81–94. doi:10.1111/j.1742-4658.2009.07429.x
   PubMed Web of Science ®Google Scholar
• Ju T, Brewer K, D’Souza A, Cummings RD, Canfield WM. Cloning and expression of human core 1 β1,3-galactosyltransferase. J Biol Chem. 2002;277(1):178–186. doi:10.1074/jbc.M109060200
   PubMed Web of Science ®Google Scholar
• Fu J, Gerhardt H, McDaniel JM, et al. Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J Clin Invest. 2008;118(11):3725–3737. doi:10.1172/JCI36077
   PubMed Web of Science ®Google Scholar
• Xia L, Ju T, Westmuckett A, et al. Defective angiogenesis and fatal embryonic hemorrhage in mice lacking core 1-derived O-glycans. J Cell Biol. 2004;164(3):451–459. doi:10.1083/jcb.200311112
   PubMed Web of Science ®Google Scholar
• Bergstrom K, Fu J, Johansson MEV, et al. Core 1- and 3-derived O-glycans collectively maintain the colonic mucus barrier and protect against spontaneous colitis in mice. Mucosal Immunol. 2017;10(1):91–103. doi:10.1038/mi.2016.45
   PubMed Web of Science ®Google Scholar
• Bergstrom KSB, Xia L. Mucin-type O-glycans and their roles in intestinal homeostasis. Glycobiology. 2013;23(9):1026–1037. doi:10.1093/glycob/cwt045
   PubMed Web of Science ®Google Scholar
• An G, Wei B, Xia B, et al. Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J Exp Med. 2007;204(6):1417–1429. doi:10.1084/jem.20061929
   PubMed Web of Science ®Google Scholar
• Thomsson KA, Holmén-Larsson JM, Angström J, Johansson ME, Xia L, Hansson GC. Detailed O-glycomics of the Muc2 mucin from colon of wild-type, core 1- and core 3-transferase-deficient mice highlights differences compared with human MUC2. Glycobiology. 2012;22(8):1128–1139. doi:10.1093/glycob/cws083
   PubMed Web of Science ®Google Scholar
• Reinoso Webb C, Koboziev I, Furr KL, Grisham MB. Protective and pro-inflammatory roles of intestinal bacteria. Pathophysiology. 2016;23(2):67–80. doi:10.1016/j.pathophys.2016.02.002
   PubMedGoogle Scholar
• Rawls JF, Mahowald MA, Ley RE, Gordon JI. Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell. 2006;127(2):423–433. doi:10.1016/j.cell.2006.08.043
   PubMed Web of Science ®Google Scholar
• Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science. 2005;307(5717):1915–1920. doi:10.1126/science.1104816
   PubMed Web of Science ®Google Scholar
• Spor A, Koren O, Ley R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol. 2011;9(4):279–290. doi:10.1038/nrmicro2540
   PubMed Web of Science ®Google Scholar
• Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature. 2003;422(6931):522–526. doi:10.1038/nature01520
   PubMed Web of Science ®Google Scholar
• Bevins CL. Paneth cell defensins: key effector molecules of innate immunity. Biochem Soc Trans. 2006;34(Pt 2):263–266. doi:10.1042/BST0340263
   PubMedGoogle Scholar
• Sommer F, Adam N, Johansson MEV, Xia L, Hansson GC, Bäckhed F. Altered mucus glycosylation in core 1 O-glycan-deficient mice affects microbiota composition and intestinal architecture. PLoS One. 2014;9(1):e85254. doi:10.1371/journal.pone.0085254
   PubMed Web of Science ®Google Scholar
• Staubach F, Künzel S, Baines AC, et al. Expression of the blood-group-related glycosyltransferase B4galnt2 influences the intestinal microbiota in mice. ISME J. 2012;6(7):1345–1355. doi:10.1038/ismej.2011.204
   PubMed Web of Science ®Google Scholar
• Kudelka MR, Hinrichs BH, Darby T, et al. Cosmc is an X-linked inflammatory bowel disease risk gene that spatially regulates gut microbiota and contributes to sex-specific risk. Proc Natl Acad Sci U S A. 2016;113(51):14787–14792. doi:10.1073/pnas.1612158114
   PubMed Web of Science ®Google Scholar
• Rausch P, Rehman A, Künzel S, et al. Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype. Proc Natl Acad Sci U S A. 2011;108(47):19030–19035. doi:10.1073/pnas.1106408108
   PubMed Web of Science ®Google Scholar
• Nakayama J, Yeh JC, Misra AK, Ito S, Katsuyama T, Fukuda M. Expression cloning of a human alpha1, 4-N-acetylglucosaminyltransferase that forms GlcNAcalpha1–>4Galbeta–>R, a glycan specifically expressed in the gastric gland mucous cell-type mucin. Proc Natl Acad Sci U S A. 1999;96(16):8991–8996. doi:10.1073/pnas.96.16.8991
   PubMed Web of Science ®Google Scholar
• Karasawa F, Shiota A, Goso Y, et al. Essential role of gastric gland mucin in preventing gastric cancer in mice. J Clin Invest. 2012;122(3):923–934. doi:10.1172/JCI59087
   PubMed Web of Science ®Google Scholar
• Etienne-Mesmin L, Chassaing B, Desvaux M, et al. Experimental models to study intestinal microbes-mucus interactions in health and disease. FEMS Microbiol Rev. 2019;43(5):457–489.
   PubMed Web of Science ®Google Scholar
• Bergstrom K, Shan X, Casero D, et al. Proximal colon-derived O-glycosylated mucus encapsulates and modulates the microbiota. Science. 2020;370(6515):467–472.
   PubMed Web of Science ®Google Scholar
• Liu F, Fu J, Bergstrom K, et al. Core 1-derived mucin-type O-glycosylation protects against spontaneous gastritis and gastric cancer. J Exp Med. 2020;217:1. doi:10.1084/jem.20182325
   PubMed Web of Science ®Google Scholar
• Van Klinken BJ, Dekker J, Büller HA, Einerhand AW. Mucin gene structure and expression: protection vs. adhesion. Am J Physiol. 1995;269(5 Pt 1):G613–G627.
   PubMedGoogle Scholar
• Martín-Sosa S, Martín M-J, Hueso P. The sialylated fraction of milk oligosaccharides is partially responsible for binding to enterotoxigenic and uropathogenic Escherichia coli human strains. J Nutr. 2002;132(10):3067–3072. doi:10.1093/jn/131.10.3067
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Cervantes LE, Ramos P, Chavez-Munguia B, Newburg DS. Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. J Biol Chem. 2003;278(16):14112–14120. doi:10.1074/jbc.M207744200
   PubMed Web of Science ®Google Scholar
• Mahdavi J, Pirinccioglu N, Oldfield NJ, et al. A novel O-linked glycan modulates Campylobacter jejuni major outer membrane protein-mediated adhesion to human histo-blood group antigens and chicken colonization. Open Biol. 2014;4:130202. doi:10.1098/rsob.130202
   PubMed Web of Science ®Google Scholar
• Poole J, Day CJ, von Itzstein M, Paton JC, Jennings MP. Glycointeractions in bacterial pathogenesis. Nat Rev Microbiol. 2018;16(7):440–452. doi:10.1038/s41579-018-0007-2
   PubMed Web of Science ®Google Scholar
• Erdem AL, Avelino F, Xicohtencatl-Cortes J, Girón JA. Host protein binding and adhesive properties of H6 and H7 flagella of attaching and effacing Escherichia coli. J Bacteriol. 2007;189(20):7426–7435. doi:10.1128/JB.00464-07
   PubMed Web of Science ®Google Scholar
• Ramamurthy T, Nandy RK, Mukhopadhyay AK, et al. Virulence regulation and innate host response in the pathogenicity of Vibrio cholerae. Front Cell Infect Microbiol. 2020;10:572096. doi:10.3389/fcimb.2020.572096
   PubMed Web of Science ®Google Scholar
• Guzman-Aranguez A, Argüeso P. Structure and biological roles of mucin-type O-glycans at the ocular surface. Ocul Surf. 2010;8(1):8–17. doi:10.1016/S1542-0124(12)70213-6
   PubMed Web of Science ®Google Scholar
• Sumiyoshi M, Ricciuto J, Tisdale A, Gipson IK, Mantelli F, Argüeso P. Antiadhesive character of mucin O-glycans at the apical surface of corneal epithelial cells. Invest Ophthalmol Vis Sci. 2008;49(1):197–203. doi:10.1167/iovs.07-1038
   PubMed Web of Science ®Google Scholar
• Xia B, Royall JA, Damera G, Sachdev GP, Cummings RD. Altered O-glycosylation and sulfation of airway mucins associated with cystic fibrosis. Glycobiology. 2005;15(8):747–775. doi:10.1093/glycob/cwi061
   PubMed Web of Science ®Google Scholar
• Vogt SL, Peña-Díaz J, Finlay BB. Chemical communication in the gut: effects of microbiota-generated metabolites on gastrointestinal bacterial pathogens. Anaerobe. 2015;34:106–115. doi:10.1016/j.anaerobe.2015.05.002
   PubMed Web of Science ®Google Scholar
• Wheeler KM, Cárcamo-Oyarce G, Turner BS, et al. Mucin glycans attenuate the virulence of Pseudomonas aeruginosa in infection. Nat Microbiol. 2019;4(12):2146–2154. doi:10.1038/s41564-019-0581-8
   PubMed Web of Science ®Google Scholar
• Alemka A, Clyne M, Shanahan F, Tompkins T, Corcionivoschi N, Bourke B. Probiotic colonization of the adherent mucus layer of HT29MTXE12 cells attenuates Campylobacter jejuni virulence properties. Infect Immun. 2010;78(6):2812–2822. doi:10.1128/IAI.01249-09
   PubMed Web of Science ®Google Scholar
• Wang BX, Wheeler KM, Cady KC, et al. Mucin glycans signal through the sensor kinase rets to inhibit virulence-associated traits in Pseudomonas aeruginosa. Curr Biol. 2021;31(1):90–102.e7. doi:10.1016/j.cub.2020.09.088
   PubMed Web of Science ®Google Scholar
• Koropatkin NM, Cameron EA, Martens EC. How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol. 2012;10(5):323–335. doi:10.1038/nrmicro2746
   PubMed Web of Science ®Google Scholar
• Yamada T, Hino S, Iijima H, et al. Mucin O-glycans facilitate symbiosynthesis to maintain gut immune homeostasis. EBioMedicine. 2019;48:513–525. doi:10.1016/j.ebiom.2019.09.008
   PubMed Web of Science ®Google Scholar
• Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol. 2004;54(Pt 5):1469–1476. doi:10.1099/ijs.0.02873-0
   PubMedGoogle Scholar
• Ottman N, Geerlings SY, Aalvink S, de Vos WM, Belzer C. Action and function of Akkermansia muciniphila in microbiome ecology, health and disease. Best Pract Res Clin Gastroenterol. 2017;31(6):637–642. doi:10.1016/j.bpg.2017.10.001
   PubMed Web of Science ®Google Scholar
• Sonnenburg JL, Xu J, Leip DD, et al. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science. 2005;307(5717):1955–1959. doi:10.1126/science.1109051
   PubMed Web of Science ®Google Scholar
• Wrzosek L, Miquel S, Noordine M-L, et al. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol. 2013;11:61. doi:10.1186/1741-7007-11-61
   PubMed Web of Science ®Google Scholar
• Png CW, Lindén SK, Gilshenan KS, et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol. 2010;105(11):2420–2428. doi:10.1038/ajg.2010.281
   PubMed Web of Science ®Google Scholar
• Katoh T, Ojima MN, Sakanaka M, Ashida H, Gotoh A, Katayama T. Enzymatic adaptation of to host glycans, viewed from glycoside hydrolyases and carbohydrate-binding modules. Microorganisms. 2020;8(4):481. doi:10.3390/microorganisms8040481
   PubMed Web of Science ®Google Scholar
• Turroni F, Bottacini F, Foroni E, et al. Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. Proc Natl Acad Sci U S A. 2010;107(45):19514–19519. doi:10.1073/pnas.1011100107
   PubMed Web of Science ®Google Scholar
• Garrido D, Kim JH, German JB, Raybould HE, Mills DA. Oligosaccharide binding proteins from Bifidobacterium longum subsp. infantis reveal a preference for host glycans. PLoS One. 2011;6(3):e17315. doi:10.1371/journal.pone.0017315
   PubMed Web of Science ®Google Scholar
• Marcobal A, Barboza M, Sonnenburg ED, et al. Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. Cell Host Microbe. 2011;10(5):507–514. doi:10.1016/j.chom.2011.10.007
   PubMed Web of Science ®Google Scholar
• Luijkx YMCA, Bleumink NMC, Jiang J, et al. Bacteroides fragilis fucosidases facilitate growth and invasion of Campylobacter jejuni in the presence of mucins. Cell Microbiol. 2020;22(12):e13252. doi:10.1111/cmi.13252
   PubMed Web of Science ®Google Scholar
• Crost EH, Tailford LE, Le Gall G, Fons M, Henrissat B, Juge N. Utilisation of mucin glycans by the human gut symbiont Ruminococcus gnavus is strain-dependent. PLoS One. 2013;8(10):e76341. doi:10.1371/journal.pone.0076341
   PubMed Web of Science ®Google Scholar
• Coyne MJ, Reinap B, Lee MM, Comstock LE. Human symbionts use a host-like pathway for surface fucosylation. Science. 2005;307(5716):1778–1781. doi:10.1126/science.1106469
   PubMed Web of Science ®Google Scholar
• Ryan FJ, Ahern AM, Fitzgerald RS, et al. Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease. Nat Commun. 2020;11(1):1512. doi:10.1038/s41467-020-15342-5
   PubMed Web of Science ®Google Scholar
• Garrett WS. The gut microbiota and colon cancer. Science. 2019;364(6446):1133–1135. doi:10.1126/science.aaw2367
   PubMed Web of Science ®Google Scholar
• Hino S, Mizushima T, Kaneko K, et al. Mucin-derived O-glycans act as endogenous fiber and sustain mucosal immune homeostasis via short-chain fatty acid production in rat cecum. J Nutr. 2020;150(10):2656–2665. doi:10.1093/jn/nxaa097
   PubMed Web of Science ®Google Scholar
• Levy GN, Aminoff D. Purification and properties of alpha-N-acetylgalactosaminidase from Clostridium perfringens. J Biol Chem. 1980;255(24):11737–11742. doi:10.1016/S0021-9258(19)70196-3
   PubMed Web of Science ®Google Scholar
• Prizont R. Degradation of intestinal glycoproteins by pathogenic Shigella flexneri. Infect Immun. 1982;36(2):615–620. doi:10.1128/iai.36.2.615-620.1982
   PubMed Web of Science ®Google Scholar
• Matos R, Fonseca KL, Mereiter S, et al. Infection up-regulates sialyl Lewis X expression in the lung epithelium. Microorganisms. 2021;9(1):99. doi:10.3390/microorganisms9010099
   PubMed Web of Science ®Google Scholar
• Sharma R, Schumacher U, Ronaasen V, Coates M. Rat intestinal mucosal responses to a microbial flora and different diets. Gut. 1995;36(2):209–214. doi:10.1136/gut.36.2.209
   PubMed Web of Science ®Google Scholar
• Burger-van Paassen N, Vincent A, Puiman PJ, et al. The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection. Biochem J. 2009;420(2):211–219. doi:10.1042/BJ20082222
   PubMed Web of Science ®Google Scholar
• Gaudier E, Jarry A, Blottière HM, et al. Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose. Am J Physiol Gastrointest Liver Physiol. 2004;287(6):G1168–G1174. doi:10.1152/ajpgi.00219.2004
   PubMed Web of Science ®Google Scholar
• Hatayama H, Iwashita J, Kuwajima A, Abe T. The short chain fatty acid, butyrate, stimulates MUC2 mucin production in the human colon cancer cell line, LS174T. Biochem Biophys Res Commun. 2007;356(3):599–603. doi:10.1016/j.bbrc.2007.03.025
   PubMed Web of Science ®Google Scholar
• Cooke CL, An HJ, Kim J, et al. Modification of gastric mucin oligosaccharide expression in rhesus macaques after infection with Helicobacter pylori. Gastroenterology. 2009;137(3):1061–1071.e8. doi:10.1053/j.gastro.2009.04.014
   PubMed Web of Science ®Google Scholar
• Venkatakrishnan V, Quintana-Hayashi MP, Mahu M, Haesebrouck F, Pasmans F, Lindén SK. Brachyspira hyodysenteriae infection regulates mucin glycosylation synthesis inducing an increased expression of Core-2 O-glycans in porcine colon. J Proteome Res. 2017;16(4):1728–1742. doi:10.1021/acs.jproteome.7b00002
   PubMed Web of Science ®Google Scholar
• Macia L, Thorburn AN, Binge LC, et al. Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases. Immunol Rev. 2012;245(1):164–176. doi:10.1111/j.1600-065X.2011.01080.x
   PubMedGoogle Scholar
• Perez-Lopez A, Behnsen J, Nuccio S-P, Raffatellu M. Mucosal immunity to pathogenic intestinal bacteria. Nat Rev Immunol. 2016;16(3):135–148. doi:10.1038/nri.2015.17
   PubMed Web of Science ®Google Scholar
• Kurashima Y, Kiyono H. Mucosal ecological network of epithelium and immune cells for gut homeostasis and tissue healing. Annu Rev Immunol. 2017;35:119–147. doi:10.1146/annurev-immunol-051116-052424
   PubMed Web of Science ®Google Scholar
• Shan M, Gentile M, Yeiser JR, et al. Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals. Science. 2013;342(6157):447–453. doi:10.1126/science.1237910
   PubMed Web of Science ®Google Scholar
• Okumura R, Takeda K. Roles of intestinal epithelial cells in the maintenance of gut homeostasis. Exp Mol Med. 2017;49(5):e338. doi:10.1038/emm.2017.20
   PubMedGoogle Scholar
• de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006;6(1):24–37. doi:10.1038/nrc1782
   PubMed Web of Science ®Google Scholar
• Kudelka MR, Stowell SR, Cummings RD, Neish AS. Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD. Nat Rev Gastroenterol Hepatol. 2020;17(10):597–617.
   PubMed Web of Science ®Google Scholar
• Cascio S, Faylo JL, Sciurba JC, et al. Abnormally glycosylated MUC1 establishes a positive feedback circuit of inflammatory cytokines, mediated by NF-κB p65 and EzH2, in colitis-associated cancer. Oncotarget. 2017;8(62):105284–105298. doi:10.18632/oncotarget.22168
   PubMedGoogle Scholar
• Carrascal MA, Severino PF, Guadalupe Cabral M, et al. Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells. Mol Oncol. 2014;8(3):753–765. doi:10.1016/j.molonc.2014.02.008
   PubMed Web of Science ®Google Scholar
• Ogata S, Maimonis PJ, Itzkowitz SH. Mucins bearing the cancer-associated sialosyl-Tn antigen mediate inhibition of natural killer cell cytotoxicity. Cancer Res. 1992;52(17):4741–4746.
   PubMed Web of Science ®Google Scholar
• Videira PA, Amado IF, Crespo HJ, et al. Surface alpha 2-3- and alpha 2-6-sialylation of human monocytes and derived dendritic cells and its influence on endocytosis. Glycoconj J. 2008;25(3):259–268. doi:10.1007/s10719-007-9092-6
   PubMed Web of Science ®Google Scholar
• Lu P, Burger-van Paassen N, van der Sluis M, et al. Colonic gene expression patterns of mucin Muc2 knockout mice reveal various phases in colitis development. Inflamm Bowel Dis. 2011;17(10):2047–2057. doi:10.1002/ibd.21592
   PubMed Web of Science ®Google Scholar
• Han X, Ding S, Jiang H, Liu G. Roles of macrophages in the development and treatment of gut inflammation. Front Cell Dev Biol. 2021;9:625423. doi:10.3389/fcell.2021.625423
   PubMed Web of Science ®Google Scholar
• Kvorjak M, Ahmed Y, Miller ML, et al. Cross-talk between colon cells and macrophages increases ST6GALNAC1 and MUC1-sTn expression in ulcerative colitis and colitis-associated colon cancer. Cancer Immunol Res. 2020;8(2):167–178. doi:10.1158/2326-6066.CIR-19-0514
   PubMed Web of Science ®Google Scholar
• Wakui H, Fuseya S, Suzuki R, et al. Incomplete clearance of apoptotic cells by core 1-derived O-glycan-deficient resident peritoneal macrophages. Biochem Biophys Res Commun. 2018;495(2):2017–2023. doi:10.1016/j.bbrc.2017.12.066
   PubMed Web of Science ®Google Scholar
• Gurram RK, Zhu J. Orchestration between ILC2s and Th2 cells in shaping type 2 immune responses. Cell Mol Immunol. 2019;16(3):225–235. doi:10.1038/s41423-019-0210-8
   PubMed Web of Science ®Google Scholar
• McDermott JR, Humphreys NE, Forman SP, Donaldson DD, Grencis RK. Intraepithelial NK cell-derived IL-13 induces intestinal pathology associated with nematode infection. J Immunol. 2005;175(5):3207–3213. doi:10.4049/jimmunol.175.5.3207
   PubMed Web of Science ®Google Scholar
• Smids C, Horjus Talabur Horje CS, Drylewicz J, et al. Intestinal T cell profiling in inflammatory bowel disease: linking T cell subsets to disease activity and disease course. J Crohns Colitis. 2018;12(4):465–475. doi:10.1093/ecco-jcc/jjx160
   PubMed Web of Science ®Google Scholar
• Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448(7152):427–434. doi:10.1038/nature06005
   PubMed Web of Science ®Google Scholar
• Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573–621. doi:10.1146/annurev-immunol-030409-101225
   PubMed Web of Science ®Google Scholar
• Nishida A, Nagahama K, Imaeda H, et al. Inducible colitis-associated glycome capable of stimulating the proliferation of memory CD4+ T cells. J Exp Med. 2012;209(13):2383–2394. doi:10.1084/jem.20112631
   PubMed Web of Science ®Google Scholar
• Ohnmacht C, Park J-H, Cording S, et al. MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORγt+ T cells. Science. 2015;349(6251):989–993. doi:10.1126/science.aac4263
   PubMed Web of Science ®Google Scholar
• Sefik E, Geva-Zatorsky N, Oh S, et al. MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORγ2 regulatory T cells. Science. 2015;349(6251):993–997. doi:10.1126/science.aaa9420
   PubMed Web of Science ®Google Scholar
• Jacobs JP, Lin L, Goudarzi M, et al. Microbial, metabolomic, and immunologic dynamics in a relapsing genetic mouse model of colitis induced by T-synthase deficiency. Gut Microbes. 2017;8(1):1–16. doi:10.1080/19490976.2016.1257469
   PubMed Web of Science ®Google Scholar
• Brown SJ, Miller AM, Cowan PJ, et al. Altered immune system glycosylation causes colitis in alpha1,2-fucosyltransferase transgenic mice. Inflamm Bowel Dis. 2004;10(5):546–556. doi:10.1097/00054725-200409000-00008
   PubMed Web of Science ®Google Scholar